STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Healthcare Biotechnology
chemistry

Rallybio Collaborates with Johnson & Johnson to Tackle Rare Disease FNAIT

byLiliana Vida
April 11, 2024
in Biotechnology, Small-Cap
Reading Time: 1 min read
Share on TwitterShare on LinkedIn

Partnership Aims to Develop Therapeutic Solutions for Fetal and Neonatal Alloimmune Thrombocytopenia

Rallybio Corporation (RLYB) has announced a collaboration with Johnson & Johnson to advance therapeutic approaches for reducing the risk of fetal and neonatal alloimmune thrombocytopenia (FNAIT). This collaboration includes a $6.6 million equity investment from Johnson & Johnson Innovation – JJDC, Inc.

Rallybio’s focus lies in developing RLYB212, a human monoclonal anti-HPA-1a antibody designed to prevent pregnant individuals from alloimmunizing, thereby mitigating the risk of FNAIT in fetuses and newborns. With plans to initiate a Phase 2 dose confirmation study for RLYB212 in the second half of 2024, Rallybio aims to address the critical need for preventative treatment options in individuals at higher risk of FNAIT.

The collaboration with Johnson & Johnson involves funding to raise awareness of Johnson & Johnson’s FNAIT clinical program alongside Rallybio’s ongoing natural history study. Together, the companies aspire to drive awareness, screening, and therapeutic advancements to combat FNAIT, ultimately improving outcomes for affected individuals.

Read original press release:here

You might like this article:Vertex Pharmaceuticals to Acquire Alpine Immune Sciences in $4.9 Billion Deal

Previous Post

Vertex Pharmaceuticals to Acquire Alpine Immune Sciences in $4.9 Billion Deal

Next Post

Candel Therapeutics’ CAN-2409 Receives FDA Orphan Drug Designation for Pancreatic Cancer

Related Posts

scientist

Purple Biotech Reaches Key Manufacturing Milestone for Groundbreaking Tri-Specific Antibody IM1240

byLuca Blaumann
October 29, 2025
0

Achievement validates CAPTN-3 platform scalability and advances IM1240 toward first-in-human clinical trials in 2026 Purple Biotech (PPBT), a clinical-stage biotechnology...

Co-Diagnostics Expands Global Reach with New Saudi Joint Venture

byLuca Blaumann
October 27, 2025
0

CoMira Diagnostics to Localize PCR Manufacturing and Healthcare Innovation Across KSA and 18 MENA Countries Co-Diagnostics (CODX), a leading molecular...

investing

Datavault AI and Wellgistics Partner to Revolutionize Prescription Tracking with Blockchain Technology

byLiliana Vida
October 24, 2025
0

Collaboration aims to enhance transparency, efficiency, and patient safety through smart contract integration Datavault AI (DVLT), a leader in AI-powered...

Next Post
chemistry-2

Candel Therapeutics' CAN-2409 Receives FDA Orphan Drug Designation for Pancreatic Cancer

Latest News

Alphabet Tops $100 Billion Quarter as AI Cloud Deals Power Record Growth

Microsoft Reports Strong Q3 Results Driven by Cloud and AI Momentum

Meta Beats on Revenue, Misses EPS as One-Time Tax Charge Weighs on Q3

Purple Biotech Reaches Key Manufacturing Milestone for Groundbreaking Tri-Specific Antibody IM1240

Orion Group Holdings Delivers Strong Q3 Results and Raises 2025 Guidance

Based on Your Interest

nvidia-chip
Artificial Intelligence

Nvidia Partners with U.S. Department of Energy to Build Seven AI Supercomputers

October 28, 2025
investing
Artificial Intelligence

Qualcomm Enters the AI Data Center Battle with Powerful New AI200 and AI250 Chips

October 27, 2025
Biotechnology

Co-Diagnostics Expands Global Reach with New Saudi Joint Venture

October 27, 2025

Recommended

Artificial Intelligence

Datavault AI and Wellgistics Partner to Revolutionize Prescription Tracking with Blockchain Technology

October 24, 2025
Large-Cap

AMD Shares Surge as IBM Taps Its Chips for Quantum Computing Breakthrough

October 24, 2025
Large-Cap

Intel Surges After Strong Q3 Earnings Beat, But Manufacturing Challenges Remain

October 23, 2025
Auto Manufacturers

Ford Beats Q3 Estimates but Cuts 2025 Outlook Following Supplier Fire

October 23, 2025
Biotechnology

Scienture Launches Commercial Sales of Arbli™, the First FDA-Approved Ready-to-Use Losartan Suspension

October 23, 2025
Stoxpo

Follow us on social media:

Highlights

  • Alphabet Tops $100 Billion Quarter as AI Cloud Deals Power Record Growth
  • Microsoft Reports Strong Q3 Results Driven by Cloud and AI Momentum
  • Meta Beats on Revenue, Misses EPS as One-Time Tax Charge Weighs on Q3
  • Purple Biotech Reaches Key Manufacturing Milestone for Groundbreaking Tri-Specific Antibody IM1240
  • Orion Group Holdings Delivers Strong Q3 Results and Raises 2025 Guidance

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

Alphabet Tops $100 Billion Quarter as AI Cloud Deals Power Record Growth

October 29, 2025

Microsoft Reports Strong Q3 Results Driven by Cloud and AI Momentum

October 29, 2025
investing

Meta Beats on Revenue, Misses EPS as One-Time Tax Charge Weighs on Q3

October 29, 2025
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.